Search - tctmd.com

Displaying 1 - 20 of 21

Sort: Relevancy | Date

News Conference News CRT 2023

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

Yael L. Maxwell

February 28, 2023

News Opinion CV Team Dispatch

November 2021 News Roundup

L.A. McKeown

November 01, 2021

News Daily News

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

Yael L. Maxwell

June 18, 2019

News Daily News

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

Yael L. Maxwell

September 02, 2016

News Daily News

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

Yael L. Maxwell

August 10, 2016

News Daily News

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

Yael L. Maxwell

July 15, 2015

News Daily News

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

Yael L. Maxwell

July 15, 2015

News Daily News

一项研究探索了抗凝血对房颤和肾病患者的作用

Yael L. Maxwell

December 10, 2014

News Daily News

Role of Anticoagulation Explored in Patients With A-Fib, Renal Disease

Yael L. Maxwell

December 10, 2014

News Daily News

Estudio del Papel que juega la Anticoagulación en Pacientes con FA y Enfermedad Renal

Yael L. Maxwell

December 10, 2014

News Conference News EuroPCR 2014

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Yael L. Maxwell

May 22, 2014

News Conference News EuroPCR 2014

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

Yael L. Maxwell

May 22, 2014

News Conference News ACC 2014

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Yael L. Maxwell

April 03, 2014

News Conference News ACC 2014

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Yael L. Maxwell

March 30, 2014

News Conference News ACC 2014

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

Yael L. Maxwell

March 29, 2014

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY：达比加群在不同肾功能患者中安全、有效

Yael L. Maxwell

December 30, 2013

News Conference News AHA 2013

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Yael L. Maxwell

November 16, 2013

Advertisement

Renal Denervation in Black Patients: SYMPLICITY HTN 3 Reassures at 36 Months

November 2021 News Roundup

FDA Class I Recall for PTA Catheters Due to Unexpected Balloon Bursting

FDA: Vascu-Guard Patch Associated With Bleeding, Death After Carotid Endarterectomy

New-Onset A-Fib, Chronic Kidney Disease Are Risk Factors For Stroke After TAVR, Meta-Analysis Shows

ADVANCE结果发布：卒中发生率随着TAVR的进步而降低

ADVANCE Published: Stroke Rate Diminishing as TAVR Evolves

ADVANCE Publicado: el Índice de ACV Disminuye a Medida que Evoluciona la TAVR

一项研究探索了抗凝血对房颤和肾病患者的作用

Role of Anticoagulation Explored in Patients With A-Fib, Renal Disease

Estudio del Papel que juega la Anticoagulación en Pacientes con FA y Enfermedad Renal

SYMPLICITY HTN-3: Predictors of Response Still Relevant After Trial’s Negative Findings

Global SYMPLICITY Substudy Teases out Reasons for Non-response in Real-World Patients

ACC/i2 2014: Cardiologists Carefully Consider TAVR, Renal Denervation

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Renal Denervation Fails to Meet Efficacy Endpoints Compared with Placebo Procedure

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

RE-LY：达比加群在不同肾功能患者中安全、有效

Long-term Outcomes with Renal Denervation Show Sustained Benefit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content